Native rat lactotrophs express thyrotrophin-releasing hormonedependent K ϩ currents consisting of fast and slow deactivating components that are both sensitive to the class III antiarrhythmic drugs that block the eag-related gene (ERG) K ϩ current (I ERG ). Here we describe in MMQ prolactin-releasing pituitary cells the isolation of the slowly deactivating longlasting component (I ERGS ), which, unlike the fast component (I ERGF ), is insensitive to verapamil 2 M but sensitive to a novel scorpion toxin (ErgTx-2) that hardly affects I ERGF . The time constants of I ERGS activation, deactivation, and recovery from inactivation are more than one order of magnitude greater than in I ERGF , and the voltage-dependent inactivation is left-shifted by ϳ25 mV. The very slow MMQ firing frequency (ϳ0.2 Hz) investigated in perforated patch is increased approximately four times by anti-arrhythmic agents, by ErgTx-2, and by the abrupt I ERGS deactivation. Prolactin secretion in the presence of anti-arrhythmics is three-to fourfold higher in comparison with controls. We provide evidence from I ERGS and I ERGF simulations in a firing model cell to indicate that only I ERGS has an accommodating role during the experimentally observed very slow firing. Thus, we suggest that I ERGS potently modulates both firing and prolactin release in lactotroph cells.
Native rat lactotrophs express thyrotrophin-releasing hormonedependent K ϩ currents consisting of fast and slow deactivating components that are both sensitive to the class III antiarrhythmic drugs that block the eag-related gene (ERG) K ϩ current (I ERG ). Here we describe in MMQ prolactin-releasing pituitary cells the isolation of the slowly deactivating longlasting component (I ERGS ), which, unlike the fast component (I ERGF ), is insensitive to verapamil 2 M but sensitive to a novel scorpion toxin (ErgTx-2) that hardly affects I ERGF . The time constants of I ERGS activation, deactivation, and recovery from inactivation are more than one order of magnitude greater than in I ERGF , and the voltage-dependent inactivation is left-shifted by ϳ25 mV. The very slow MMQ firing frequency (ϳ0.2 Hz) investigated in perforated patch is increased approximately four times by anti-arrhythmic agents, by ErgTx-2, and by the abrupt I ERGS deactivation. Prolactin secretion in the presence of anti-arrhythmics is three-to fourfold higher in comparison with controls. We provide evidence from I ERGS and I ERGF simulations in a firing model cell to indicate that only I ERGS has an accommodating role during the experimentally observed very slow firing. Thus, we suggest that I ERGS potently modulates both firing and prolactin release in lactotroph cells.
Key words: K ϩ channels; lactotrophs; firing; anterior pituitary cells; erg genes; prolactin release Thyrotrophin-releasing hormone (TRH) induces a biphasic increase in prolactin secretion with a brief initial hyperpolarization (attributable to Ca 2ϩ -dependent K ϩ channels) and a long-lasting depolarization (Ozawa and Sand, 1986) . Experiments in GH 3 or GH 3 /B 6 tumor-derived pituitary cells have revealed that a TRHdependent inward-rectifying current (Bauer et al., 1990; Barros et al., 1992 Barros et al., , 1994 ) is sustained by eag-related gene (ERG) channels (Barros et al., 1997; Bauer, 1998) . Studies of TRH action and prolactin release have also been performed in native pituitary cells (Corrette et al., 1996; Sankaranarayanan and Simasko, 1996; Schäfer et al., 1999) , but the current in these cells is characterized by a double exponential deactivation with time constants of the order of 5-6 sec, a left-shifted voltage-dependent activation with respect to ERG K ϩ current (I ERG ), and a slightly different sensitivity to the drug E-4031.
ERG potassium channels (Warmke and Ganetzky, 1994; Trudeau et al., 1995; Titus et al., 1997) regulate the duration of heart action potential (Sanguinetti et al., 1995) and also sustain spike-frequency adaptation in neurons (Chiesa et al., 1997) and human pancreatic ␤-cells (Rosati et al., 2000) . The peculiar properties of the ERG activation gate (Schönherr et al., 1999) are such that they lead to the accumulation of an outward I ERG that is sufficient to inhibit firing.
The experiments described here were performed using the pituitary tumor-derived MMQ cell line, which, like native lactotrophs, secretes prolactin and is responsive to the inhibitory action of dopamine (Judd et al., 1988) . We show that the properties of the MMQ inwardly rectifying current are very similar to those found in normal lactotrophs (Sankaranarayanan and Simasko, 1996; Schäfer et al., 1999) insofar as they have a fastdeactivating component (I ERGF ) and a long-lasting component (I ERGS ), both of which are sensitive to typical ERG inhibitors such as WAY 123,398, E-4031, ErgTx-1 (Gurrola et al., 1999) , and caffeine (Barros et al., 1997) . The fast and slow deactivating components can be distinguished by a novel scorpion toxin that specifically blocks only ERGS, by verapamil, an ERG blocker that blocks ERGF but does not affect ERGS (up to 2-3 M), and by using a biophysical approach; furthermore, the [K ϩ ] o dependences of the two components are different. The functional role of ERGF and ERGS components was investigated by current clamping MMQ cells in the perforated whole-cell mode and applying various pharmacological and biophysical manipulations. We also determined the crucial role of I ERGS in ultra-slow firing by means of a model reconstruction of its biophysical properties. Finally, we investigated the dependence of prolactin release on ERGF/ERGS blockers and found, by using the RNase protection technique, that all three of the known erg genes are expressed in these cells, albeit at different levels.
Some of the preliminary results have been published previously in abstract form .
MATERIALS AND METHODS
Cell culture. The MMQ pituitary cell line (kindly provided by Dr. I. S. L ogin, University of Virginia School of Medicine, Charlottesville, VA) was cultured in RPM I-1640 medium containing 7.5% horse serum (Invitrogen) and 2.5% FC S (Euroclone).
Solutions and drugs. The standard extracellular solution contained (in mM): NaC l 130, KC l 5, C aC l 2 2, MgC l 2 2, H EPES-NaOH 10, D- The pipette solution used for the perforated patch experiments contained (in mM): K ϩ -aspartate 140, NaC l 10, MgC l 2 2, H EPES-KOH 10, amphotericin B (Invitrogen) 150 g /ml, pH 7.30. The action potentials (APs) and firing were initially recorded in current clamp by means of an Axopatch 200A in I fast mode (Axon Instruments, Foster C ity CA) and subsequently by means of the MultiC lamp 700A, which makes a perfect voltage recording instead of adapting a patch amplifier to current clamp (Magistretti et al., 1996) . We used WAY-123,398 (Spinelli et al., 1993) (WAY) as a specific ERG blocker, although all of its effects can also be obtained using E-4031 (Faravelli et al., 1996) . WAY (from Dr. W. Spinelli, Wyeth-Ayerst Research, Princeton, NJ) was dissolved in distilled water to make 5 mM stock solutions. E-4031 was a generous gift from Sanofi Recherche (Montpellier, France). In addition to E-4031 and WAY-123,398 we also used haloperidol (Sigma, St. L ouis, MO), terfenadine, and astemizole (kindly provided by Prof. Maurizio Taglialatela, University of Naples, Naples, Italy).
P urification and chemical anal ysis of Ergtoxin-2. The novel Ergtoxinlike peptide used in this study was purified from the Mexican scorpion Centruroides noxius Hoffmann by means of a combination of chromatographic separations, starting with Sephadex G-50 gel filtration, followed by two steps of HPLC. In the last chromatographic step, the peptide elutes as a single symmetrical component. When submitted to automatic Edman degradation, it gives a unique sequence with the three most N-terminal amino acids: Gly-Arg-Asp. The molecular mass obtained in a Finnegan LCQ-DUO mass spectrometer was 4783. The fact that only one signal was obtained showed that the peptide was homogeneous. This peptide has 43 amino acid residues and contains 4 disulfide bridges (G. Gurrola, L. D. Possani, unpublished observations). It is different from the Ergtoxin described previously by our group (Gurrola et al., 1999) and was called C n ErgT x-2: C n stands for C. noxius, and the 2 indicates that it is the second such peptide to be f ully characterized from this venom.
Patch-clamp recordings and data anal ysis. The currents were recorded at room temperature as described previously (Faravelli et al., 1996) with 4 -6 M⍀ pipette resistance; cell capacitance and series resistance errors were caref ully compensated for (85-90%) before each voltage-clamp protocol run. The extracellular solutions were delivered through a ninehole (0.6 mm) remote-controlled linear positioner, with an average response time of 2-3 sec, placed near the cell under study. The ERG and ERGS inactivation curves were obtained by plotting the normalized peak chord conductance (G peak ϭ I(peak)/(V M Ϫ E K )) against membrane potential V M . To compensate for the deactivation present at the peak (especially at membrane potentials negative to Ϫ80), we extrapolated the exponential decaying fitting of deactivation to the onset of the test pulse (Smith et al., 1996) . To study voltage-dependent activation, the peak tail currents elicited at Ϫ120 mV were normalized to maximum and plotted against the preconditioning voltage. pC lamp 8 (Axon Instruments) and Origin 4.1 (Microcal Inc.) software were used routinely during data acquisition and analysis.
Prolactin release. Prolactin release was assayed using an enzyme immunoassay (EIA) system (Amersham Biosciences, Milano, Italy). Briefly, the cells were incubated for 1 hr with the test substances, and then the medium was collected and stored at Ϫ80°C until assay. The amount of prolactin released by the cells was measured by evaluating the competition between the hormone present in the samples and a fixed quantity of biotin-labeled rat prolactin for a limited amount of rat prolactin antibody immobilized on precoated microtiter wells. The actual concentration of prolactin in the samples was evaluated by comparing the obtained results with those derived from a standard curve prepared using known concentrations of rat prolactin standards.
Molecular biolog y. The RNase protection assays (RPAs) were performed according to Dixon and McK innon (1994) , with some modifications. Briefly, total RNA was extracted from freshly collected rat brains and retinas or semiconfluent MMQ cell cultures using the guanidinum /isothiocyanate method (Maniatis et al., 1989) , and 50 g was hybridized overnight at 48°C with 32 P-UTP-labeled RNA probes. The rat erg probes used for these experiments were the same as those used by Shi et al. (1997) , linearized with HindIII and transcribed with T3 polymerase. Rat c yclophillin (Ambion) was used as an internal loading control. Digestion with RNase A (40 g /ml) and T1 (2 g /ml) was then performed for 1 hr at room temperature. Five micrograms of yeast tRNA were used as a negative control for the probe selfprotection bands. Finally, the samples were run on a 6.6% polyacrylamide gel and exposed for between 1 and 7 d.
Model. The analysis shown in Figures 2C (inset) and 8 were obtained using the Axon Engineer Pro program (AEON Software, Madison, W I) and followed the classical scheme (Shibasaki, 1987; Sanguinetti and Jurkiewicz, 1990) for interpreting I Kr . This scheme describes I ERGF and I ERGS as the product of the two voltage-dependent variables, which are here called a( V) (activation) and h( V) (inactivation) according to the
, where g max is the maximal conductance of the f ully open channels (Faravelli et al., 1996) . The I ERGS inward currents predicted by this model are shown in Figure 2C (inset, last panel ).
To minimize the number of conductances and create the continuous firing of heart-like action potentials, we used the interplay of voltagedependent I C a and I K s currents having properties that are of no great concern here. As explained in Results, to annul the activation variables of ERGF and ERGS, we forced the holding potential at Ϫ60 mV at the beginning of the experiment so that the development of the action of either ERGF or ERGS could be easily seen. The maximal conductance ratios were the following: g K s /g C a /g Leak /g ERGF /g ERGS ϭ 1:0.17:0.002:0.011: 0.044. The reversal potential for I Leak was set to Ϫ55 mV. We used the classical formalism of Hodgkin and Huxley with the following forward (␣) and backward (␤) rate constants for ERGF and ERGS models:
RESULTS
The inwardly rectifying current of MMQ cells can be separated into a quickly and a slowly deactivating component with a different sensitivity to verapamil As in native lactotrophs (Schäfer et al., 1999) , the inwardly rectifying current of MMQ cells consists of a transient component and a long-lasting component, both of which are inhibited by 1 M E-4031 and WAY123,398, as well as by other ERG blockers such as haloperidol (2 M), astemizole (1 M), and terfenadine (2 M). In native lactotrophs, the long-lasting component can be deactivated after prolonged hyperpolarization to Ϫ120 mV for 10 sec, and it reappears only after a depolarizing pulse to 0 mV for 10 min (Schäfer et al., 1999) .
The ERG-like K ϩ currents in MMQ cells were recorded using a [K ϩ ] o of 40 mM (see Materials and Methods). The currents were elicited from a holding potential of 0 mV, at which the channels are open but completely inactivated, to test potentials (V T ) in the Ϫ20 to Ϫ120 range (Fig. 1, H, inset) . Consistently, they are normally seen as inward tail currents that reflect the rapid removal of inactivation, which is normally finished at peak, and a succeeding development of the deactivation process that is more or less complete and quick at different test potentials.
In MMQ cells (Fig. 1 A) , the long-lasting component f) can be completely deactivated by 30 sec conditioning to Ϫ100 mV (F); both components are blocked by WAY 123,398 (OE). However, verapamil, which is a good blocker of ERG K ϩ currents (I ERG ) (Chouabe et al., 1998; Zhang et al., 1999) , did not block the long-lasting component ( Fig. 1 B, F) at a concentration of 3 M ( D). As shown in Figure 1 B, subtraction of the current obtained in verapamil from the control current leads to a trace that has the typical time course of ERG currents ( Fig. 1 B, f-F) , which we called ERGF. This suggests that the long-lasting component is a novel pharmacologically ERG-related K ϩ current, which we called ERGS (ERG slow). Figure 1C (the same cell as that shown in Fig. 1 B) shows that the difference between the control current (OE) and the current elicited after the Ϫ100 mV conditioning (), returns a component (ERGS, -OE) with properties that are completely different from those of I ERG . A trace very similar to that shown in Figure 1C (-OE) can be obtained in Figure 1 B by subtracting a suitable amount of ERGF from the trace in verapamil (F) (Fig. 1, see legend) . To investigate the reliability of this approach, we derived the verapamil dose-response relationships for the two current components in Figure 1 D. They appear to be well separated: the IC 50 of the ERGF was 2.3 Ϯ 0.2 and that of ERGS was 19.2 Ϯ 2 M (n ϭ 5). Verapamil (3 M) had negligible effects (Chouabe et al., 1998) on the activation curve of ERGF (shift of Ϫ3.1 Ϯ 0.6 mV; n ϭ 4; data not shown) and its deactivation kinetics (Fig. 1 D, inset) .
To study the voltage-dependent properties of the MMQ currents ( Fig. 1 E-I ), we used the protocol shown in the inset to H; the control traces are shown in Figure 1 E. A 10 sec hyperpolarization to Ϫ100 mV depressed the ERGS component ( F), and this difference (E, F ) produced the traces shown in G. When the control cell ( E) was directly perfused with 3 M verapamil ( H), the resulting verapamil-sensitive currents ( I) were very similar to typical ERG currents (Arcangeli et al., 1995; Faravelli et al., 1996; Barros et al., 1997; S. Wang et al., 1997; Schönherr et al., 1999) . In conclusion, the verapamil results suggest the coexistence of two components, ERGF and ERGS, which can also be isolated biophysically by means of ERGS deactivation (at Ϫ100 mV).
The voltage dependence of deactivation and recovery from inactivation
Because the most evident property of I ERGS is its very slow deactivation, we studied this process in detail. The experimental protocol ( Fig. 2 A) consisted of two consecutive identical episodes elicited from a V H of 0 mV at suitable test potentials (ranging from Ϫ60 to Ϫ120 mV and lasting for between 240 and 12 sec) in different trials; the membrane potential between the two episodes was brought to 0 mV by means of a slow ramp to reduce contamination from delayed rectifier currents before eliciting the second episode. During the first episode, the total inward current is elicited (first epi) and completely deactivated. The time at 0 mV was sufficient to reactivate only the ERGF component, and the second elicited current (second epi) is simply I ERGF . This is shown in Figure 2 B for membrane potentials ranging from Ϫ60 to Ϫ120 mV. In each of the panels, the trace corresponding to the difference between the first and the second episode is also shown, and we assume that it represents the isolated ERGS component (notice the different time scales). This trace is shown in Figure 2C at much slower time scales to highlight the complete deactivation process. An idea of the dramatic difference in the complete time course of the deactivation process for the two components can be seen in the two superimposed records in the last panel but one. The last panel in C shows the superimposed traces at different membrane potentials. The inset represents the theoretical reconstruction according to the model described in Materials and Methods.
The ERGS and ERGF traces were fitted to double exponential decaying functions. The time constants ( 1 ERGS , 2 ERGS , 1 ERGF , 2 ERGF ) and the fractional ratio of the associated amplitudes A, Superimposed recordings elicited with the protocol shown below before ([f) and after 30 sec conditioning at Ϫ100 mV (F), and after perfusion with 1 M WAY-123398 (way, OE). Note different symbols to locate traces. B, C, Superimposed recordings elicited with the protocol shown below before (f), after the application of 3 M verapamil (ver, F, and their difference verapamilsensitive f-F), after washout (OE), and after 30 sec conditioning at Ϫ100 mV (, and their difference OE-). The unlabeled trace in B is obtained by subtracting the verapamil-sensitive trace labeled f-F multiplied by 1.6 from trace F. D, Verapamil dose-response curves of the ERGF and ERGS components; IC 50 values were 2.3 Ϯ 0.2 and 19.2 Ϯ 2 M, respectively, and the Hill coefficients were 0.94 and 1.44, respectively. Inset, Superimposed recordings of the ERGF tail currents at Ϫ100 mV under control conditions (line) and during 3 M verapamil perfusion (E); the latter trace was multiplied by 2.1. The procedure used to isolate ERGF followed that shown in C. E, Recordings elicited by the protocol shown in H, inset. F, Traces after 10 sec conditioning at Ϫ100 mV in the same cell. G, Superimposed traces obtained after subtracting the data in F from those in E. H, The traces after perfusion of 3 M verapamil (ϩ verap) in the same cell. I, Superimposed traces obtained after subtracting the data in H from those in E.
were computed from six similar experiments, the averaged data of which are shown in Table 1 . These recordings (the inward-going traces up to the peak current) were used to derive the time constants of the recovery from inactivation of ERGF and ERGS at the same membrane potentials (last two columns in Table 1 ). To calculate these time constants, we also used experiments such as those shown in Figure 1 E-G (n ϭ 4).
Because MMQ cells have a large inactivating delayed rectifier current, to evaluate the inactivation curve of ERGS we used the procedure of Smith et al. (1996) and Faravelli et al. (1996) on the normalized peak conductances from the data shown in Figures  1 H and 2 , B and C. The V 1/2 and slope of the Boltzmann fitting curves were Ϫ74.2 Ϯ 3.4 and 12.7 Ϯ 2.7 mV, which were different from those derived from the ERGF current data (Ϫ48.1 Ϯ 1.9 and 28.2 Ϯ 2.1 mV): the ERGS value of V 1/2 was left-shifted by ϳ26 mV, and the slope was steeper.
These results indicate that the voltage-dependent processes governing the ERGS and ERGF components are different because there is no overlapping of the time constants derived from the two components. Because the fast component is dominant, the ERGF data agree with those of Snyders and Chaudhary (1996) , Schledermann et al. (2001) , and Zhou et al. (1998) , although the last were derived at 37°C. However, ERGS deactivation is a double exponential process that is complete at Ϫ60 mV, thus indicating that activation should start at more depolarized membrane potentials, as shown below.
I ERGS activation: distribution of I ERGS in MMQ cells
To investigate the voltage-dependent activation of I ERGS , we estimated the original amount at different potentials by applying short pulses at Ϫ100 or Ϫ120 mV (pulses T0, T1, or Tn) (Fig. 3A) . At the beginning of each experiment, the ERGS component was checked (test pulse T0) and then completely deactivated by pulses of either Ϫ80 or Ϫ100 mV lasting 100 or 15 sec, respectively (as suggested by the data shown in Table 1 ). The test pulses were always preceded by a 15 sec V H at 0 mV, which was necessary to reactivate the ERGF (but not the ERGS) component and to check whether ERGS was deactivated. Furthermore, membrane potential was conditioned to different levels ranging from Ϫ60 to ϩ40 mV for periods of time ranging from 15 to 720 sec. Additional test pulses (Tn) returned the amount of the consecutively activated ERGS component.
To exclude the possibility that the repetitive application of brief tail pulses might produce a small deactivation of ERGS current and perturb the pure voltage-dependent activation process, we tested the available I ERGS at different times (i.e., 50, 100, and 400 sec), resetting the conditions each time by completely deactivat- The slow ramps to reach the holding level after the long pulses were chosen to reduce the activation of the delayed rectifier currents. B, The panels from left to right correspond to experiments done at Ϫ60, Ϫ80, Ϫ100, and Ϫ120 mV. The appropriate time scale for each was chosen to show the ERGF (1st epi) and the ERGS (2nd epi Ϫ 1st epi) components. Note particularly the very slow recovery from inactivation of the ERGS component in comparison with ERGF. The traces in each panel show the first and second episodes (WAY-corrected) and the difference between the two. C, The panels show (same experiments shown in B) only ERGS at much longer time scales to illustrate the complete process of deactivation. In the next to last panel, the second episode taken from the correspondent B panel is superimposed as indicated. In the last panel on the right, the traces elicited at Ϫ60, Ϫ80, and Ϫ100 are superimposed on that elicited at Ϫ120 mV. Inset, The traces were obtained using the computer model for ERGS (see Materials and Methods and Results). Time constant of recovery from inactivation ( rec ERGS, rec ERGF; n ϭ 10).
Lecchi et al.
• Long-Lasting K ϩ Channels in Lactotrophs J. Neurosci., May 1, 2002, 22(9):3414-3425 3417 ing I ERGS . We concluded that four to five brief test pulses during the exponential activation process did not significantly affect the time-dependent development of activation. Figure 3B shows a typical experiment used to study the activation time constants and steady-state activation at three V M values. The insets show the traces from experiments performed at conditioning potentials of ϩ40, 0, and Ϫ40 mV, with the trace circles indicating the initial current (T0). The traces with the smallest long-lasting current represent the starting level (T1) of the activation process ( just after deactivation). The intermediate traces were elicited at different times (Fig. 3B , ‚, Ⅺ, छ). The increasing amount of ERGS, normalized to the maximal level derived from the amplitudes observed before ERGS deactivation, was plotted for V M ϭ ϩ40 (‚), 0 (Ⅺ), and Ϫ40 mV (छ), and the data were fitted to exponential curves to obtain the activation time constants (V M ϭ ϩ40 mV, a ϭ 120 Ϯ 6.3 sec; 0 mV, a ϭ 114 Ϯ 4.5 sec; Ϫ40 mV, a ϭ 325 Ϯ 16 sec). Activation was complete at ϩ40 and 0 mV, but the activation reached a maximal level of 0.31 at Ϫ40 mV, which suggests a V 1/2 activation that is more positive than Ϫ40 mV. Similar experiments (n ϭ 11) were performed by scanning membrane potentials ranging from Ϫ60 to ϩ40. The normalized activation data versus membrane potential were fitted to a Boltzmann curve characterized by the following V 1/2 and slope values (n ϭ 12) of Ϫ37.2 Ϯ 3.5 and 4.9 Ϯ 1.1 mV, to be compared with the ERGF values of Ϫ33.7 Ϯ 1.9 and 6.5 Ϯ 1.5 (n ϭ 8) typical of MMQ cells. The time constants obtained at V M ϭ ϩ40 and 0 mV were pooled because the values were not significantly different (the average was 123 Ϯ 9 sec), and those obtained at Ϫ20 and Ϫ40 mV were 173 Ϯ 11 sec and 289 Ϯ 32 sec, respectively (n ϭ 10). For comparison, the I ERGF values were 0.4 Ϯ 0.08, 2.8 Ϯ 0.23, and 9.8 Ϯ 0.4 sec (n ϭ 10).
The activation was quicker in the few cells (ϳ11%) almost devoid of the ERGF component (Fig. 3 D, E) . It can be seen both from the superimposed traces and from the fractional activation (plotted in C) that the time constants (22 Ϯ 0.7 sec, n ϭ 3; 11.2 Ϯ 0.9, n ϭ 5) were much faster than in the more common cases in which ERGF is normally present. Because the reasons for this difference are still unclear, these cells (ϳ11%; see below) were excluded from the analysis described above.
This observation suggested that the ERGS fraction in relation to the total current in MMQ cells should be analyzed. By examining the ERGS amplitude at 400 msec (when ERGF is almost completely deactivated), it is possible to classify the cells on the basis of the percentage of I ERGS present (Fig. 2) . On the contrary, after ERGS is completely deactivated, the peak of the transient current represents the amount of the uncontaminated ERGF component. We therefore classified the cells into six categories on the basis of the percentage of I ERGS versus the sum of I ERGF and I ERGS . The cells were categorized as shown in Table 2 , and it can be concluded that ϳ42% of the cells have a low expression of ERGS component [I ERGS /(I ERGF ϩ I ERGS ) ratio Ͻ34%]. This observation, as we will see during the current-clamp experiments, will have some relevance for the suggested physiological role of the ERGS component. The protocol used for eliciting the pulses for the tests (T0-Tn, 400 msec at Ϫ100 mV or 140 msec at Ϫ120 mV), the deactivation of ERGS, and the conditioning levels of activation. B, The exponential time course of I ERGS ( t)/I ERGS (max) ratio of the experiments shown in the insets at conditioning levels of ϩ40 (‚), 0 (Ⅺ), and Ϫ40 mV (छ); the three insets show the superimposed traces elicited (at Ϫ120 mV) in the same cell with the protocol shown in A, but at different conditioning levels, at the following times: V M ϭ ϩ40 and 0 mV, 20, 60, and 270 sec; V M ϭ Ϫ40 mV, 60, 240, 480, and 720 sec. The traces in small circles represent the test made before deactivation (T0, see A) . C, The exponential time course of I ERGS ( t)/ I ERGS (max) ratio of the experiments shown in D and E derive from cells belonging to categories 5 (F) and 6 (f) ( Table 2 ) at a conditioning level of 0 mV. D, Superimposed traces elicited in a category 5 cell, with test pulses (at Ϫ100 mV) at the times corresponding to the symbols (F) of the plot shown in C. E, Superimposed traces elicited in a category 6 cell, with test pulses (at Ϫ100 mV) at the times corresponding to the symbols ([f) of the plot shown in C. The specific action of a scorpion toxin on ERGS deactivation
Because anti-arrhythmic blockers (Schäfer et al., 1999 ) (data not shown) and the scorpion ErgTx toxin characterized by us (Gurrola et al., 1999; Scaloni et al., 2000) were equally effective on ERGS and ERGF, we looked for a peptide that could distinguish the two components and isolated a different toxin (ErgTx-2) from fraction II of the venom of the Mexican scorpion C. noxius Hoffmann (see Materials and Methods). The effect of a single application of 10 g/ml ErgTx-2 on the ERGS component was fast and completely reversible, as shown in Figure 4 A-C. Figure 4 D shows the effect obtained in the same cell after the inhibition of the ERGS component by means of prolonged hyperpolarization to Ϫ100 mV. Comparison of the traces in B and D indicates that the two modes of ERGS inhibition are not completely equivalent: the traces in D are more similar to typical ERG currents than those observed during toxin application. This behavior is still being studied in our laboratory, but it is worth noting that the drug modestly affects the peak current represented mainly by I ERGF . Figure 4 , E and F, shows the specific inhibition induced by the toxin on the very slow deactivation of ERGS recorded at Ϫ100 mV under control conditions and on the application of the drug. The experiment was performed according to the pulse protocol shown at the bottom of the panels. The current was tested briefly (f), the I ERGS was recorded during deactivation (Ⅺ) and retested after a 10 min recovery (F) to check that the reactivation was complete, and finally deactivation was recorded (E) during toxin application. Figure 4 F shows the superimposed traces of the current before and during the action of the toxin, to be compared with the last panel but one in Figure 2C , which was obtained by the prolonged hyperpolarization to Ϫ100 mV.
Finally, Figure 4G shows the dose-response curve of the peptide for the two components, indicating an IC 50 value of 2.02 Ϯ 0.2 g/ml for ERGS and 1.44 Ϯ 0.2 g/ml for ERGF. Because the ERGS/ERGF ratio of maximal block was 1:0.19, it can be concluded that the specific effect on the ERGF component is negligible [see the inset to D where the action of ErgTx-2 (10 g/ml) and WAY (1 M) are compared]. These experiments indicate that a peptide present in fraction II of a scorpion venom can be used to distinguish ERGS and the ERGF currents.
The effects of [K ϩ ] o
The I ERG dependence on [K ϩ ] o has been studied extensively in cardiac cells (Shibasaki 1987; Sanguinetti et al., 1990) , oocytes (Sanguinetti et al., 1995; Wang et al., 1997) and neuroblastoma cells (Arcangeli et al., 1995) , and it has been found that the maximal conductance (open channel) has a strong dependence on [K ϩ ] o at variance with respect to other K ϩ channel families and that the properties of the inactivation are right-shifted at high [K ϩ ] o values . Because the two ERGF and ERGS components could belong to two different molecular structures, it should be feasible to find possible differences in this biophysical feature.
We 
. Effects of scorpion toxin ErgTx-2 on the long-lasting ERGS component. A-D,
The superimposed currents elicited with the protocol shown below before (A), during the application of the toxin (10 g/ml) ( B), after 15 sec of washout ( C), and after 60 sec hyperpolarization to Ϫ100 mV without toxin ( D). Data in A-D are from the same cell. E, F, Superimposed recordings elicited with the protocol shown below before (f), during the 30 sec at Ϫ100 mV (Ⅺ), which deactivated I ERGS , after 600 sec holding at 0 mV (F, which shows that I ERGS was reactivated), and during the application of ErgTx-2 (E, 30 sec at Ϫ100 mV). Data in E and F are from the same cell. G, Dose-response curve of the fractional I ERGF or I ERGS blocked as a function of ErgTx-2 concentration. The procedure used to isolate ERGF followed that shown in Figure 1C . The data were fitted by using the following equation: fraction of blocked current ϭ
, with an IC 50 of 2.02 Ϯ 0.2 g/ml (n ϭ 4) and p ϭ 1.64 Ϯ 0.2 for ERGS and 1.44 Ϯ 0.2 g/ml (n ϭ 4) and p ϭ 2.5 Ϯ 0.9 for the ERGF component, but the maximal block for this component was 0.19 Ϯ 0.02. Inset, The effect of ErgTx-2 on the ERGF component is shown in the three traces corresponding to control (line), 10 g/ml ErgTx-2 (E), and 1 M WAY 123,398 (line).
properties or that their dependence of the inactivation curve on [K ϩ ] o is different , or both. Because all the experiments were done at very negative potentials where the inactivation is nearly at its maximal value (ϳ1), we think that the putative shift of the inactivation curve should be negligible. Therefore this result should be added to those previously found to be useful for characterizing ERGF and ERGS.
Properties of action potentials and firing in MMQ cells
Because the firing properties of MMQ cells have not yet been investigated, we studied them in the light of the role of the ERGF and ERGS K ϩ currents. To characterize the diversity of the APs, we measured the maximum peak level (V PEAK ), plateau potential (V PL ATEAU ), afterhyperpolarization (AHP), duration (t D ), and instantaneous frequency (F i ) calculated as the reciprocal of the interspike interval. The peak was usually well beyond ϩ10 mV, and the V PL ATEAU was approximately Ϫ4 mV. The AHP was in the range Ϫ60 to Ϫ46 mV, and t D and F i showed the largest scatter: when the duration was below 100 msec, the plateau was absent (Fig. 5D ). There are examples of a duration comparable with that typically observed in the heart, but much larger durations were also common. F i is rarely constant, and large differences are possible in the 0.01-1 Hz range. A summary of the average characterizing parameters under control conditions is listed in Table 4 .
Although it reduced the AP peak, TTX (0.6 M) did not block firing, but nickel (50 M) and nifedipine (5 M) always inhibited firing, thus suggesting that the APs in MMQ cells are mainly sustained by Ca 2ϩ currents; consistently, BAYK (1 M), a dihydropyridine that increases the L-type Ca 2ϩ channel open duration, considerably prolonged AP duration. The typical properties of single spontaneous APs under perforated-patch conditions are shown in Figure 5 (insets). Dopamine, the physiological neurotransmitter that inhibits prolactin release, induced a marked hyperpolarization that was sufficient to stop the firing (Fig. 5A) ; this effect was observed in ϳ50% of the cells (n ϭ 35).
On the whole, these data suggest that most of the MMQ cells have the typical properties of native lactotrophs, which are known to be usually as spontaneously active as ours (Sankaranarayanan and Simasko, 1998) . As discussed below, this explains the presence of a small amount of background prolactin release (Meucci et al., 1992) .
Action of ERG/ERGS-blockers
Various effects were observed in 23 of 35 MMQ cells (66%) that were current clamped by using the perforated-patch technique before and after the application of ERG channels blockers, the most consistent being a significant increase in firing frequency (Table 4, 
third column).
A sample of the similar effects obtained after perfusing the cells with different ERG blockers is shown in Figure 5B -E. Figure  5B shows increased firing frequency accompanied by a small reduction in AP duration and AHP; Figure 5C shows increased firing frequency without any alteration in AP duration and the disappearance of AHP. Experiments shown in Figure 5 , D and E, were quantitatively analyzed. Figure 5D shows a cell that was spontaneously firing at ϳ1 Hz. After WAY application, two variables were monitored: instantaneous frequency and AHP, plotted as a white line or white circles, respectively. WAY application led to a reversible threefold increase in frequency and a decrease in AHP (4 mV). The traces before and during the application of WAY are shown at fast time resolution in the Figure 5D (inset). The AP wave shape was not altered except for the interspike interval, which was more depolarized during drug application. The cell shown in Figure 5E fired spontaneously at a much slower frequency (0.05) than the cell shown in D; the effect of E-4031 affected both the firing and AHP, increasing AP frequency (Ⅺ) by approximately fourfold and decreasing AHP (E) by ϳ6 mV. The wave shape of the action potential was also marginally changed, and the AHP was mostly inhibited during drug application.
The effects of long hyperpolarizations to ؊100 mV or scorpion toxin ErgTx-2 on firing properties
We have shown above that there are two ways to inhibit I ERGS :
(1) a long hyperpolarization to Ϫ100 mV and (2) the application of ErgTx-2 toxin. These methods should have different effects when applied to firing cells: the first deactivates I ERGS by clamping the cell to Ϫ100 mV, and the subsequent restoration of V REST returns a momentarily I ERGS -free cell that will presumably fire at a higher frequency and thus progressively reactivate I ERGS itself; the second should alter cell firing in a way that is reversible by washout.
We recorded the effect of a 40 -50 sec hyperpolarization to Ϫ100 mV (obtained by means of suitable current injection) in 10 cells firing regularly at rest. Five of these cells showed a sudden increase in firing frequency after the offset of the hyperpolarization. The data from two successful cells are shown in Figure 6 , A and B, and an exemplary nonresponding cell is shown in C. The plot of instantaneous frequency (E; the line is a running average) in A and B shows a net change in frequency change after the conditioning, and a subsequent slow decline to the original frequency (straight line).
The effect of blocking I ERGS by ErgTx-2 was observed in five experiments (of eight), the results of two of which are shown in Figure 6 , D and E; one unsuccessful experiment is shown in F. The toxin increased firing frequency from ϳ0.08 Hz under control conditions to 0.22 Hz during drug administration in the first cell ( D) and from almost zero to 0.35 Hz in the second cell ( E). There was no change in AP duration or AHP. In conclusion, the very low firing frequency of the cells in which these effects were observed again suggests and confirms that the specific role of I ERGS is to produce adaptation at such low-frequency firing.
Interestingly, WAY application was ineffective in four of the five unsuccessful experiments based on the first method and in all three unsuccessful experiments based on the second method. It can be argued that when I ERGS expression is too small to affect MMQ cell firing, I ERG is unable to substitute it because it is unable to produce adaptation of the firing at very slow frequencies.
In conclusion, all of these experiments investigating the specific functional role of the ERGS component indicate that I ERGS 1.14 Ϯ 0.09 (n ϭ 5) 40 1 80 0.76 Ϯ 0.03 (n ϭ 5)
The data derive from tail currents elicited at Ϫ100 mV, from V H ϭ 0.
sustains an accommodation process at low firing rates at which ERG action is ineffective.
The action of anti-arrhythmic blockers on prolactin secretion
The strong hyperexcitability observed in Figure 6 prompted us to verif y whether this response is f unctionally related to prolactin release . As explained in Materials and Methods, prolactin secretion was measured (n ϭ 8) before and after perf usion with the blocker WAY-123,398 in three different conditions: [K ϩ ] o ϭ 5 mM, which corresponds to control; [K ϩ ] o ϭ 5 mM ϩ 10 M WAY, which corresponds to a complete blockade of the ERG and ERGS components; and [K ϩ ] o ϭ 40 mM, which corresponds to an almost f ully depolarized condition. The results indicate that there is a measurable prolactin release of 2.05 Ϯ 0.1 ng /ml under purely physiological conditions (5 mM [K ϩ ] o ) (Meucci et al., 1992) ; f urthermore, at 10 M WAY (6.91 Ϯ 0.7 ng /ml) and 40 mM [K ϩ ] o (5.12 Ϯ 0.5 ng /ml), prolactin increased 3.37 and 2.5 times, respectively, in comparison with baseline. These data are in line with the effects on cell firing.
The presence of different erg genes
The expression of the three currently known erg genes was studied in MMQ cells using the RPA (Shi et al., 1997) . Rat brain was chosen as the control for erg1 and erg3, and rat retina was the control for erg2 expression. As shown in Figure 7 , all of the three erg genes are expressed in MMQ cells, with erg1 being the most abundantly represented and erg3 being expressed at very low levels: an erg3-protected band (Fig. 7C) can be detected only after 1 week of autoradiographic film exposure (Fig. 7C, inset) . It is worth noting that the additional bands, for all of the erg genes tested and detectable in both control tissue and MMQ cells, may have been caused by alternative gene splicing.
Firing properties predicted by a model cell with ERGF or ERGS channels
Using the procedures indicated in Materials and Methods, we investigated the effects of adding either I ERGF or I ERGS to a model simulating spontaneous firing. The onset was forced from a membrane potential of Ϫ60 mV (at which ERG and ERGS channels are completely closed), and after 2 sec the holding current was removed and the cell was allowed to fire and adjust its firing rate toward steady-state equilibrium. The result of this 200 
The observed changes (mean Ϯ SE, n) in some of the parameters during perfusion with antiarrhythmics or ErgTx-2 and after I ERGS deactivation (30 sec at Ϫ100 mV) are shown in the last three columns in millivolts (mV) or as percentages (%) of the control values. ND, Not detected; Min/max, minimum/maximum.
sec simulation is shown in Figure 8 A, which shows that the cell has an almost constant firing frequency of 0.16 Hz (Fig. 8 A, right scale, Ⅺ). The small decrease in action potential peaks during the 200 sec period was caused by long-term changes from the nonsteady-state onset. When ERGF conductance was added (Fig. 8 B) , firing remained constant (but at the lower value of 0.09 Hz), and AHP increased from Ϫ60 to Ϫ67 mV. Conversely, when only ERGS conductance was added (Fig. 8 D) , firing started at 0.13 Hz, but after 200 sec it dropped at a frequency of 0.05 Hz, which means an accommodation of 2.6 times. These results mimic those observed in Figure 6 , A and B, that were obtained under similar experimental conditions, and those summarized in Table 4 that show an average frequency increase of ϳ200% during drug or biophysical blockade of ERGS. The effect of adding both ERGF and ERGS components is shown in Figure 8D (superimposed, in small open circles) .
To clarify the reasons behind the effects seen in Figure 8 , B and D, we plotted (Fig. 8C,E Figure 8 F shows that I ERGS is zero at peak AP, whereas in H I ERGF is almost zero during the spike interval and reaches a peak during AP repolarization, thus aiding the increase in AHP.
Because these currents depend on the product of activation and inactivation voltage-and time-dependent variables, these were also plotted (in Fig. 8G for ERGS and I for ERGF ). Although ERGS inactivation (dotted line) follows the AP timing, the number of open ERGS channels (continuous line) is an almost steadystate variable; conversely, the inactivation and number of ERGF open channels both reflect the time course of the AP. Unlike during fast spiking (Chiesa et al., 1997; Schönherr et al., 1999) , at Presence of erg transcripts in MMQ cells. RNA extracted from rat brain, rat retina, and MMQ cells was probed using the rat (r) erg1, erg2, and erg3 clones. Rat brain RNA was used as a control for erg1 and erg3, and rat retina RNA was used as a control for erg2 expression. Rat c yclophillin (Ambion) was used as an internal control, and yeast t-RNA was used as a negative control for the probe selfprotection bands. A, erg1 [three-dimensional (3D) exposure)]; B, erg2 (1D exposure); C, erg3 (1D exposure); inset, higher magnification of the area indicated in C, taken from an autoradiographic film exposed for 7 d. c yc, C yclophillin. such a low firing frequency there is no accumulation of I ERGF , whereas its repolarizing role is shown in Fig. 8 H during the 1-sec-long AP. Although I ERGF is much larger than I ERGS during the AP, it becomes almost negligible during the interspike interval, which gives ERGF channels sufficient time to close. This is not true for ERGS channels, which are unable to close during the 20 sec of the interspike interval (Fig. 8G) .
Our model helps to clarify the different roles of ERGF and ERGS channels during the very slow firing typical of lactotroph cells. The low firing rates are controlled by ERGS channels down to extremely low frequencies of the order of the reciprocal of the deactivation time constant (ϳ100 -150 sec at average cell resting potential).
DISCUSSION

The properties distinguishing I ERGS from I ERGF
The K ϩ current in MMQ cells is similar to that originally observed in native rat lactotrophs by Sankaranarayanan and Simasko (1996) (interpreted as an M-like current) and more recently described by Schäfer et al. (1999) . It consists of two components (I ERGF and I ERGS ) variably distributed among the cell population, in agreement with the native cell data ( Table 2) . The two components can be distinguished in at least four ways.
(1) An appropriate concentration of verapamil inhibits a large fraction of the fast-deactivating current without influencing ERGS (Fig. 1 A) . (2) Appropriate voltage-clamp experiments made it possible to study the ultra-slow processes of ERGS deactivation and activation that are kinetically distinct from those measurable for the ERGF component (Figs. 1-3 , Table 1 ). (3) A pure peptide (ErgTx-2) obtained from the scorpion C. noxius Hoffmann venom selectively inhibits I ERGS (Fig. 4) . (4) (Table 3 ). The currents responsible for the two components share the structural motifs involved in channel interactions with antiarrhythmic agents, but all of their other properties (especially their voltage dependence) lead to the conclusion that they correspond to two different molecular entities. For the sake of simplicity, we shall treat these components as different channels.
Firing properties in cells expressing ERG channels and novel putative roles of ERGS channels
It has been shown that ERG channel blockade or mutated ERG channels in different tissues lead to various effects, such as the prolongation of the heart action potential, the depolarization of neuroblastoma and glomus cells of the rabbit carotid body (Arcangeli et al., 1995; Faravelli et al., 1996; Bianchi et al., 1998; Overholt et al., 2000) , an increase in neuronal firing (Chiesa et al., 1997) and GH 3 /B 6 and GH 3 cells (Barros et al., 1997; Weinsberg et al., 1997) , contractions in opossum esophageal circular smooth muscle (Akbarali et al., 1999) , and increased firing and insulin secretion in human ␤-cells (Rosati et al., 2000) . The functional roles of ERG currents can therefore be divided into three categories.
(1) Inactivated K ϩ channels are rescued during the decaying phase of a plateau potential in cardiac AP. This is caused by recovery from inactivation (a fast process) and leads to the immediate availability of ERG channels that is useful for obtaining faster hyperpolarization of the membrane. The increase in the number of available channels overcompensates for the reduction in the driving force of K ϩ ions and therefore produces a peak of outward current that rapidly repolarizes the AP, as shown in Figure 8 B, C,H [also see Ono and Ito (1995) ]. A pronounced increase in AHP can also be predicted (Fig. 8) .
(2) In spontaneously firing cells, or cells that are induced to fire short (5-50 msec) APs at a higher rate than 2-3 Hz, only a few (5-10%) ERG channels are open/inactivated. The very slow deactivation of ERG channels at V REST values of approximately Ϫ55 mV generates an accumulation of I ERG that functions as a brake (Schönherr et al., 1999) and produces spike frequency accommodation (Chiesa et al., 1997; Selyanko et al., 1999; Overholt et al., 2000; Rosati et al., 2000) .
(3) The overlap of the voltage-dependent activation and inactivation processes produces a window current that, in nonexcit- able cells such as neuroblastomas, is responsible for the regulation of V REST and its depolarization in the presence of a blocker (Arcangeli et al., 1995; Faravelli et al., 1996; Overholt et al., 2000) .
Although these roles are distinct, it frequently happens that they inter-react according to the percentage of I ERG in respect to the total K ϩ currents. It is not always easy to distinguish which is more important. However, other potential contributions to these phenomena may come from other K ϩ channels, and although we can confirm that apamin and charibdotoxin (blockers of K (C a) channels) do not greatly affect the firing in MMQ cells, we cannot exclude other channels (Sankaranarayanan and Simasko, 1998) .
In conclusion, we suggest that the functional role of I ERGS in MMQ cells is centered on ultra-low-frequency firing accommodation. This is based on (1) the biophysical characterization of I ERGS , (2) the results of the hyperexcitability produced either by ErgTx-2 blockade or hyperpolarization-induced I ERGS inhibition, and (3) the results of the reconstructed firing in the I ERGS model cell. This can be clearly seen in Figure 8 E where the very long time constants of I ERGS activation/deactivation lead to the accumulation of open channels (Fig. 8G ) during the I ERGS growing phase, and it has been produced experimentally (Fig. 6 A, B) . Moreover, in the model, the simultaneous presence of ERGS and ERGF components (Fig. 8 D, E) indicates that specifically at very slow frequencies (see the end of the record) the presence of ERGF does not affect the firing.
Consistency of prediction data and the experimental effects of blockers
Given the result of the classification of MMQ cells (Table 2) , which is at least qualitatively similar to that of native cells (Schä-fer et al., 1999) , it is clear that ERGF channels are present in ϳ97% of the cells. If only I ERGF were important for firing accommodation, it could be expected that ERG blockers would have a hyperexcitable effect in almost all of the experiments, but we found only a 66% success rate. On the other hand, the computer-simulated MMQ cells showed that the efficacy of ERG channels in producing an accommodation at 0.2 Hz is limited to ϳ50% (Fig. 8 A, B) , to be compared with 160% (Fig. 8 D) obtained by introducing ERGS channels. Moreover, the typical MMQ firing properties listed in Table 4 show that the average frequency is ϳ0.2 Hz, thus making it reasonable to suppose that the presence of ERG channels is scarcely effective at modulating the cell firing in a relevant fraction of the MMQ cells (Fig. 8 B) . By adding all of the cells belonging to category 4, 5 and 6, and ϳ50% of those of category 3, we obtain ϳ66%, which is consistent with the observed result.
The biophysical properties of the channels related to the erg2 and erg3 genes found in MMQ cells are incompatible with the properties of I ERGS RT-PCR experiments in normal rat lactotrophs (Schäfer et al., 1999) and in MMQ cells (Wimmers et al., 2001 ) have shown the presence of three and two (erg1, erg2) genes, respectively. Although our RPA molecular biology data also showed the presence of the erg3 gene (at a much lower level), we can confirm the suggestions of Schäfer et al. (1999) that no combination of the expressed gene conductances explains the electrophysiological data in MMQ cells. The novel current component therefore has biophysical properties that cannot be explained simply by the present molecular biology data, and further exploration of the MMQ genome is necessary.
Putative coassembly of ERG monomer with other monomers
More recently, a large number of different mRNAs have been found in native pituitary and GH 3 /B 6 cells (Wulfsen et al., 2000) , and we cannot exclude the possibility that ERG monomers may interact with other unknown monomers to form particular ion channels with combined properties. Interestingly, it has been shown that in MMQ cells injected with a point-mutated erg construct (erg1G630S), a dominant-negative suppression of the endogenous current can be observed 8 hr after injection (Wimmers et al., 2001) . This finding and the fact that both ErgTx-1 and the anti-arrhythmic drugs block completely the MMQ ERG-like currents without distinguishing between ERGF and ERGS suggests that probably the ion channels producing ERGS are built up with at least one ERGF subunit. Vice versa, the action of ErgTx-2, which seems to recognize only the ERGS fingerprint, suggests that the ERGS subunit, when present, can coassemble with ERGF-producing heterologous channels. It is also known that ERG can coassemble with small units such as MinK or MiRP1 (MinK-related peptide 1) to produce currents with different biophysical properties (McDonald et al., 1997; Abbott et al., 1999) . Because our tests in MMQ cells (data not shown) with the M current blocker XE-331 (Wang et al., 1998) were unsuccessful, we can suggest that probably ERG monomers do not assemble with KCNQ2 and KCNQ3. On the other hand, it is known that M and ERG currents can apparently coexist independently in neuroblastoma cells (Meves et al., 1999; Selyanko et al., 1999) . Experiments performed in MMQ cells with chromanol 293B (50 M), a blocker of KCNQ1 and I K s currents (Busch et al., 1997) , have also been unsuccessful (data not shown).
Concluding remarks
Measurements of the prolactin released in controls and during WAY blocker action demonstrate that the amount of released hormone is approximately as large as the hormone obtained with a prolonged and probably exhaustive high K ϩ depolarization. This suggests that the prolactin released by the cells expressing I ERGS is sufficiently large with respect to prolactin released by the 12-25% of cells devoid of I ERGS (Table 2 ). In conclusion, to set their pacemaker at the desired frequency, lactotrophs are endowed with I ERGS . This current gives the cells a negative feedback system with genuine voltage-dependent properties and thus is linked only marginally to other signaling pathways dependent on intracellular factors or [Ca 2ϩ ] i changes (Kwiecien and Hammond, 1998) . The data of Schäfer et al. (1999) showing that the ERG-like current is sensitive to TRH in native lactotrophs indicate that the working point of this feedback system is physiologically subject to hypothalamic supervision.
